Prostate biopsy—infection and prior fluoroquinolone exposure


    loading  Checking for direct PDF access through Ovid

Abstract

Prostate cancer screening has led to an increase in transrectal-ultrasonography (TRUS)-guided prostate biopsies. However, clinicians are becoming increasingly concerned that fluoroquinolone-resistant organisms are the cause of infectious complications in patients who have undergone this procedure. Two separate studies have shown that patients treated with fluoroquinolone prior to transrectal biopsy are at an increased risk of infectious complications.

    loading  Loading Related Articles